Liver cancer
Digital/ News/ News/ News/ Oncology
Median Tech debuts AI-focused unit for cancer trial support
Phil Taylor
digital, digital health, iBiopsy, imaging, Liver cancer, lung cancer, Median Technologies, Oncology
0 Comment
Market Access/ News/ News/ News/ Oncology
AZ closes on FDA verdict on tremelimumab in liver cancer
Phil Taylor
AstraZeneca, immuno-oncology, Liver cancer, Oncology, tremelimumab
0 Comment
Keytruda’s liver cancer approval secured by new study
Phil Taylor
immuno-oncology, Keytruda, Liver cancer, Merck & Co, Oncology
0 Comment
BMS pulls speedy Opdivo approval for liver cancer in US
Phil Taylor
Bristol-Myers Squibb, fda, immuno-oncology, Keytruda, Liver cancer, Merck & Co, Oncology, Opdivo
0 Comment
Exelixis’ Cabometyx misses survival target in liver cancer trial
Phil Taylor
Cabometyx, Exelixis, Ipsen, Liver cancer
0 Comment
NICE okays Roche liver cancer immunotherapy, Sanofi’s rare disease drug
Phil Taylor
aTTP, Avastin, Cablivi, Liver cancer, NICE, Roche, Sanofi, Tecentriq
0 Comment
News/ News/ Oncology/ Top stories
Merck & Co/Eisai eye kidney cancer use for immunotherapy combination
Richard Staines
cancer, Eisai, Liver cancer, Merck & Co
0 Comment
Europe approves Roche’s Tecentriq liver cancer combination
Richard Staines
Bayer, cancer, Liver cancer, Roche
0 Comment